Similarly, Surman and coauthors observed reduced IgA-producing ASCs in VAD mice following intranasal influenza vaccination [127,178], suggesting that VA administration to VAD mice enhanced these mucosal IgA Ab responses post-vaccination. This evidence concerns the gene CD79A and influenza.